JP Morgan Chase
NDRA icon

JP Morgan Chase’s ENDRA Life Sciences NDRA Stock Holding History

JP Morgan Chase’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$6.84K – 7724
2023
Q4 		$6.84K Buy
+2
New +$4.21K ﹤0.01% 6500
2023
Q3 		– Hold
0
– – – 6662
2023
Q2 		– Sell
-4
Closed -$16.2K – 7195
2023
Q1 		$16.2K Buy
4
+1
+33% +$6.79K ﹤0.01% 6019
2022
Q4 		$18K Buy
+3
New +$25.1K ﹤0.01% 5917

Other funds holding NDRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

JP Morgan Chase's NDRA Position: Q1 2024 in Review

JP Morgan Chase sold out of ENDRA Life Sciences (NDRA) in Q1 2024, closing a stake of 2 shares — an estimated $6.84K sold.

JP Morgan Chase first reported a position in NDRA in Q4 2022 and held it in 3 quarters. The position peaked at $18K in Q4 2022. 8 funds tracked by Wall St. Rank hold NDRA as of Q1 2024.

  • JP Morgan Chase reported no remaining ENDRA Life Sciences position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 2 ENDRA Life Sciences shares in Q1 2024, an estimated $6.84K.
  • JP Morgan Chase first reported a position in ENDRA Life Sciences in Q4 2022 and held it in 3 quarters.
  • JP Morgan Chase's ENDRA Life Sciences position peaked at $18K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.